Literature DB >> 17308783

Activity of praziquantel on in vitro transformed Schistosoma mansoni sporocysts.

A C A Mattos1, J R Kusel, P F P Pimenta, P M Z Coelho.   

Abstract

Praziquantel (PZQ) is effective against all the evolutive phases of Schistosoma mansoni. Infected Biomphalaria glabrata snails have their cercarial shedding interrupted when exposed to PZQ. Using primary in vitro transformed sporocysts, labeled with the probe Hoechst 33258 (indicator of membrane integrity), and lectin of Glycine max (specific for carbohydrate of N-acetylgalactosamine membrane), we evaluated the presence of lysosomes at this evolutive phase of S. mansoni, as well as the influence of PZQ on these acidic organelles and on the tegument of the sporocyst. Although the sporocyst remained alive, it was observed that there was a marked contraction of its musculature, and there occurred a change in the parasite's structure. Also, the acidic vesicles found in the sporocysts showed a larger delimited area after contact of the parasites with PZQ. Damages to the tegument was also observed, as show a well-marked labeling either with Hoechst 33258 or with lectin of Glycine max after contact of sporocysts with the drug. These results could partially explain the interruption/reduction mechanism of cercarial shedding in snails exposed to PZQ.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17308783     DOI: 10.1590/s0074-02762006000900044

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  8 in total

1.  In vivo treatment of experimental neurocysticercosis with praziquantel nanosuspensions-a metabolic approach.

Authors:  Luciana Damacena Silva; Nayana Ferreira Lima; Eva Carolina Arrua; Claudio Javier Salomon; Marina Clare Vinaud
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

Review 2.  New insight into praziquantel against various developmental stages of schistosomes.

Authors:  Wei Wu; Wei Wang; Yi-Xin Huang
Journal:  Parasitol Res       Date:  2011-10-08       Impact factor: 2.289

3.  Towards an understanding of the mechanism of action of praziquantel.

Authors:  Anthony D Aragon; Reza A Imani; Vint R Blackburn; Pauline M Cupit; Sandra D Melman; Tinopiwa Goronga; Thomas Webb; Eric S Loker; Charles Cunningham
Journal:  Mol Biochem Parasitol       Date:  2008-11-28       Impact factor: 1.759

4.  A novel bacterial pathogen of Biomphalaria glabrata: a potential weapon for schistosomiasis control?

Authors:  David Duval; Richard Galinier; Gabriel Mouahid; Eve Toulza; Jean François Allienne; Julien Portela; Christophe Calvayrac; Anne Rognon; Nathalie Arancibia; Guillaume Mitta; André Théron; Benjamin Gourbal
Journal:  PLoS Negl Trop Dis       Date:  2015-02-26

5.  Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel.

Authors:  Eglal I Amer; Iman Fathy Abou-El-Naga; Laila M Boulos; Heba S Ramadan; Salwa S Younis
Journal:  Biomedica       Date:  2022-03-01       Impact factor: 1.173

6.  Biomphalysin, a new β pore-forming toxin involved in Biomphalaria glabrata immune defense against Schistosoma mansoni.

Authors:  Richard Galinier; Julien Portela; Yves Moné; Jean François Allienne; Hélène Henri; Stéphane Delbecq; Guillaume Mitta; Benjamin Gourbal; David Duval
Journal:  PLoS Pathog       Date:  2013-03-21       Impact factor: 6.823

7.  Schistosoma mansoni in susceptible and resistant snail strains Biomphalaria tenagophila: in vivo tissue response and in vitro hemocyte interactions.

Authors:  Rafael Nacif-Pimenta; Ana Carolina Alves de Mattos; Alessandra da Silva Orfanó; Luciene Barbosa; Paulo Filemon Paolucci Pimenta; Paulo Marcos Zech Coelho
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

8.  Interaction of Biomphalaria cells in primary cultures with Schistosoma mansoni sporocysts.

Authors:  Aristeu Silva-Neto; Cristhiane Oliveira da Fonseca; Luciana Maria Silva; Paulo Marcos Zech Coelho; Consuelo Latorre Fortes-Dias
Journal:  Rev Soc Bras Med Trop       Date:  2020-11-06       Impact factor: 1.581

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.